NCT00228969已完成2 期
Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 61
研究概览
简要总结
The primary objective of this study is to evaluate the efficacy, safety, and tolerability of 4 daily doses of RWJ-333369 as adjunctive treatment of refractory partial epilepsy in subjects who are between 18 and 70 years of age, inclusive
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 79 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 18-70 years old,
- •Diagnosis of epilepsy for at least 1 year,
- •Presenting, on average, at least 3 partial onset seizures per month,
- •Currently treated with a stable dose (i.e., for at least 4 weeks) of no more than 3 anti-epileptic drugs (AEDs),
排除标准
- •Have experienced status epilepticus in the past 3 months,
- •Have any serious diseases,
- •History of major psychiatric disorders within the past 2 years.
- •Have received an experimental drug/device within the past 30 days
- •Are pregnant or breastfeeding.
研究者
研究点 (61)
Loading locations...
相似试验
已完成
2 期
A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's DiseaseAlzheimer DiseaseNCT05063539Eli Lilly and Company327
进行中（未招募）
1 期
The Safety and The Efficacy Evaluation of ET-STEM in Patients With Frontotemporal DementiaFrontotemporal DementiaNCT05315661Samsung Medical Center12
撤回
2 期
Dose-Ranging Safety and Efficacy Study of Topical Creams Containing API 31510 for the Treatment of in Situ Cutaneous Squamous Cell CarcinomaSquamous Cell CarcinomaNCT00605709BPGbio
已完成
2 期
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)ConstipationNCT01983306Bausch Health Americas, Inc.292
已完成
3 期
Safety and Efficacy Study to Treat Bacterial VaginosisBacterial VaginosisNCT01621399Medicis Global Service Corporation651